Crispr Therapeutics Ag (CRSP)

Capital Expenditure

-$3.12M

Quarterly · Period ending: · USD

CRSP logo

CRSP Capital Expenditure

Latest reported-$3.12M
CRSP Quarterly CapEx ($0.00 → -$3.12M)
High-resolution chart · PNG

CRSP capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-3,121,000
-504,000
-517,000
-74,000
-117,000
-206,000
-254,000
-219,000
-707,000
-721,000
-738,000
-2,118,000
-3,555,000
-3,059,000
-6,191,000
-6,017,000
-9,630,000
-15,350,000
-9,183,000
-37,049,000
-28,449,000
-7,024,000
-6,239,000
-5,523,000
-3,605,000
-2,991,000
-952,000
-2,461,000
-2,174,000
-1,097,000
-1,000,000
-695,000
-523,000
-555,000
-205,000
-2,994,000
-1,330,000
-3,285,000
-228,000
-1,509,000
-1,047,000
-232,000
-503,000
-549,000
-102,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.